Non-Inferiority Study of the FRESCA Airbox Positive Airway Pressure System

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

52 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-10-14

Study Completion Date

2020-01-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Prospective, open-label, randomized crossover assignment, multi-center non-inferiority study conducted in the United States

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Non-Inferiority Study of the FRESCA Mask Versus Existing CPAP Mask for Treatment of Obstructive Sleep Apnea

NCT02387476

Obstructive Sleep Apnea Sleep Apnea OSA

COMPLETED NA

Continuous Positive Airway Pressure (PAP) Titration and Treatment Versus Auto-adjusting PAP Treatment for Sleep Apnea

NCT00988351

Obstructive Sleep Apnea

COMPLETED NA

Comparison of Breathing Event Detection by a Continuous Positive Airway Pressure Device to Clinical Polysomnography

NCT01175031

Sleep Apnea Central Cheyne-Stokes Respiration Obstructive Sleep Apnea

COMPLETED NA

The POSAtive Study: Study for the Treatment of Positional Obstructive Sleep Apnea

NCT03061071

Sleep Apnea Syndromes

COMPLETED NA

Sleep Apnea in Heart Failure With Preserved Ejection Fraction

NCT05008432

Heart Failure Obstructive Sleep Apnea

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is designed to demonstrate that the FRESCA Airbox Positive Airway Pressure System is non-inferior to the existing FRESCA Positive Airway Pressure System. Subjects meeting the inclusion and exclusion criteria will be randomized to one sleep night with the existing FRESCA device programmed to fixed pressure and one sleep night with the investigational FRESCA device programmed to auto-adjusting pressure and exhale pressure relief.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sleep Apnea

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Prospective, open-label, randomized crossover assignment, multi-center study conducted in the United States

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Central sleep study scorer will be masked to assignment group

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sequence 1

FRESCA Airbox Flow Generator set to fixed pressure first, then FRESCA Airbox Generator set to auto-adjusting pressure.

Second intervention within 1 - 10 days of first intervention.

Group Type OTHER

positive airway pressure system

Intervention Type DEVICE

Positive Airway Pressure System

Sequence 2

FRESCA Airbox Flow Generator set to auto-adjusting pressure first, then FRESCA Airbox Generator set to fixed pressure.

Second intervention within 1 - 10 days of first intervention.

Group Type OTHER

positive airway pressure system

Intervention Type DEVICE

Positive Airway Pressure System

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

positive airway pressure system

Positive Airway Pressure System

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Male or female aged 22 - 75 years old.
2. BMI: ≤ 40 kg/m2.
3. Subjects diagnosed with OSA (either newly diagnosed (naive) OSA subjects or current CPAP subjects).
4. Must be able to be fitted properly with FRESCA mask.
5. Must be able to comply with all study requirements as outlined in the protocol.
6. Subject must complete a valid PSG titration night.

Exclusion Criteria

1. Subjects with non-OSA sleep disorders (including periodic limb movement (PLM) disorder and chronic insomnia).
2. Subjects with substantial central or mixed apneas (central and mixed apnea ≥ 5/hr.).
3. Subjects with prior surgical intervention for OSA.
4. Subjects with frequent or sustained episodes of O2 saturation ≤75%.
5. Subjects with obesity-related hypoventilation.
6. Subjects currently using a CPAP full face mask.
7. Subjects who are medically unstable.
8. Subjects with unstable or severe cardiovascular abnormalities (e.g., heart failure, valvular heart disease).
9. Subjects with atrial fibrillation or other arrhythmias that are not effectively controlled with medication.
10. Subjects with hypotension or uncontrolled HTN.
11. Subjects with chronic lung disease, including COPD.
12. Subjects with significant cardiopulmonary disease.
13. Subjects with ongoing severe nasal allergies or sinusitis or difficulty breathing through the nose; persistent blockage of one or both nostrils; or any nasal or facial abnormalities that would not allow adequate placement and use of the mask.
14. Subjects with surgery of the upper airway, nose, sinus or middle ear within the previous year.
15. Subjects currently working nights, rotating night shifts or with planned travel during the study period.
16. Subjects on a non-stable dose of medications or other agents that may affect sleep and/or PSG (e.g., sedatives or hypnotics).
17. Subjects who consume \> 500 mg caffeine per day (e.g., \> 8 cola-type beverages, \> 5 cups of coffee).
18. Subjects who consume \> 14 alcoholic drinks/week.
19. Subjects who are pregnant (confirmed verbally).
20. Subjects currently enrolled in any other research study.

Minimum Eligible Age

22 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No